Cite
HARVARD Citation
Iede, K. et al. (2020). Predictive implications of decreased CA19‐9 at 8 weeks during nab‐paclitaxel plus gemcitabine for the induction of second‐line chemotherapy for patients with advanced pancreatic cancer. Cancer reports. 3 (6), p. n/a. [Online].